Clinical research in ovarian cancer: consensus recommendations from the Gynecologic Cancer InterGroup

Autor: Ignace Vergote, Antonio Gonzalez-Martin, Domenica Lorusso, Charlie Gourley, Mansoor Raza Mirza, Jean-Emmanuel Kurtz, Aikou Okamoto, Kathleen Moore, Frédéric Kridelka, Iain McNeish, Alexander Reuss, Bénédicte Votan, Andreas du Bois, Sven Mahner, Isabelle Ray-Coquard, Elise C Kohn, Jonathan S Berek, David S P Tan, Nicoletta Colombo, Rongyu Zang, Nicole Concin, Dearbhaile O'Donnell, Alejandro Rauh-Hain, C Simon Herrington, Christian Marth, Andres Poveda, Keiichi Fujiwara, Gavin C E Stuart, Amit M Oza, Michael A Bookman, Christoph Grimm, Regina Berger, Ting-Chang Chang, Kazunori Ochiai, Val Gebski, Alison Davis, Philip Beale, Hannelore Denys, Vincent Vandecaveye, Francisco Jose Candido dos Reis, Maria Del Pilar Estevez Diz, Gavin Stuart, Helen MacKay, Mark Carey, David Cibula, Pavel Dundr (path), Oliver Dorigo, Jonathan Berek, Abu Saadeh, Ingrid Boere, Christianne Lok, Pluvio Coronado, Nelleke Ottevanger, David SP Tan, Joseph Ng, Antonio Gonzalez Martin, Ana Oaknin, Alejandro Perez Fidalgo, Karen Lu, Carlos López-Zavala, Eva María Gómez-García, Xavier Paoletti, Florence Joly, Michael Bookman, Rebecca Arend, Hiroyuki Fujiwara, Kosei Hasegawa, Ilan Bruchim, Dalia Tsoref, Katsutoshi Oda, Takayuki Enomoto, Dayana Michel, Hee-Seung Kim, Jung-Yun Lee, Asima Mukhopadhyay, Dionyssios Katsaros, Sandro Pignata, Giovanni Scambia, Elise Kohn, Jung-Min Lee, Shibani Nicum, Laura Farrelly, Jalid Sehouli, Maren Keller, Elena Braicu, Line Bjørge, Annika Auranen, Stephen Welch, Viola Heinzelmann, Patricia Roxburgh, Ros Glasspool, Jianqing Zhu

Publikováno v: Lancet Oncology, 23, 8, pp. e374-e384
Vergote, I, Gonzalez-Martin, A, Lorusso, D, Gourley, C, Raza Mirza, M, Kurtz, J-E, Okamoto, A, Moore, K, Kridelka, F, McNeish, I, Reuss, A, Votan, B, du Bois, A, Mahner, S, Ray-Coquard, I, C. Kohn, E, S Berek, J, SP Tan, D, Colombo, N, Zang, R, Concin, N, O'Donnell, D, Rauh-Hain, A, Herrington, C S, Marth, C, Poveda, A, Fujiwara, K, C.E Stuart, G, Oza, A & Bookman, M A 2022, ' Clinical research in ovarian cancer: consensus recommendations from the Gynecologic Cancer InterGroup ', The Lancet Oncology, vol. 23, no. 8, pp. e374-e384 . https://doi.org/10.1016/S1470-2045(22)00139-5
Lancet Oncology, 23, e374-e384

Contains fulltext : 283536.pdf (Publisher’s version ) (Closed access) The Gynecologic Cancer InterGroup (GCIG) sixth Ovarian Cancer Conference on Clinical Research was held virtually in October, 2021, following published consensus guidelines. The g

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::babbffbae78b2ae996bd86c3ee6e0ab1
https://hdl.handle.net/2066/283536

In vitro evaluation of the nematicide activity of the liquid fermentation of Purpureocillium sp. UdeA 0106 strain on pineapple and flower soils

Autor: Dayana Michel Hernández, Laura A. Hoyos, Juan Diego Medina, Nadya Lorena Cardona

Publikováno v: Agrociencia, Vol 24, Iss NE2, Pp 1-8 (2020)

Colombia is recognized as an important agricultural producer of pineapple and flowers. One of the most significant phytosanitary problems of these crops is pathogenic nematodes and it is necessary to find biocontrol alternatives for their management.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9fc0a18e7191d4fb6f5e6621109a7412
http://agrocienciauruguay.uy/ojs/index.php/agrociencia/article/view/382/417

476P Open-label phase I/II study evaluating the tolerability and antitumor activity of selinexor (SEL) and pembrolizumab (pembro) in colorectal cancer (CRC)

Autor: Maya Gottfried, P. Duic, S. Shacham, Ravit Geva, Talia Golan, E. Sbar, C. Meng, M. Kauffman, S. Sharoni, E. Netiv, Aviad Zick, Jatin J. Shah, Julia Dudnik, Fan Yang, Alona Zer, Dayana Michel, A. Shai, T. Shentzer Kutiel

Publikováno v: Annals of Oncology. 32:S569

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::7bdaaec856bbacfbf952ec0f45cf76e3
https://doi.org/10.1016/j.annonc.2021.08.997

Open-label phase 1 study evaluating the tolerability and anti-tumor activity of selinexor and pembrolizumab in colorectal cancer

Autor: Alona Zer, Maya Gottfried, Michael Kauffman, Jatin J. Shah, Fan Yang, Einat Netiv, Julia Dudnik, Sharon Shacham, Ravit Geva, J. Paul Duic, Changting Meng, Yue Zhang, Talia Golan, Shmuel Sharoni, Talia Shentzer Kutiel, Dayana Michel, Aviad Zick

Publikováno v: Journal of Clinical Oncology. 39:e15579-e15579

e15579 Background: Colorectal cancer (CRC) is the fourth leading cause of cancer-related deaths worldwide and is heterogenous in its molecular features. Checkpoint inhibitors (CPIs) are approved for only about 5% of unresectable or metastatic CRC wit

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::a73f931605cf172efad9361be275aecd
https://doi.org/10.1200/jco.2021.39.15_suppl.e15579